Clinical Trials
50 trialsWondercel-UWD3
Wondercel Biotech (ShenZhen)
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Ningbo No.2 Hospital
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
Zhejiang University
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
West China Hospital
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
Massachusetts General Hospital
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Shanghai Changzheng Hospital
A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers
Disruptive Pharma
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy
Emory University
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center
SN301A
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
BioSyngen Pte Ltd
PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer
Mayo Clinic
Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Beijing 302 Hospital
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
Northwestern University
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma
Mayo Clinic
Role of DEB-TACE Versus c-TACE in Treatment of HCC
Sohag University
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE
H. Lee Moffitt Cancer Center and Research Institute
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
Jonsson Comprehensive Cancer Center
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
Jonsson Comprehensive Cancer Center
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
Hoosier Cancer Research Network
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery
Ohio State University Comprehensive Cancer Center
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Ohio State University Comprehensive Cancer Center
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC
Fudan University
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma
Mayo Clinic
Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter Ratio
Beijing Ditan Hospital
Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)
Beijing Ditan Hospital
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA)
Beijing Ditan Hospital
Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma
Huashan Hospital
YYFZJDTRHCLT3D
Beijing Ditan Hospital
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC
Zhejiang Cancer Hospital
VEROnA
Boston Scientific Corporation
Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma
China Academy of Chinese Medical Sciences
ET1402L1-ARTEMISâ„¢2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma
First Affiliated Hospital Xi'an Jiaotong University
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial
Beijing 302 Hospital
YYFZTIHBVHCC
Beijing Ditan Hospital
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer
First Affiliated Hospital Xi'an Jiaotong University
Effectiveness of Drug Eluting TACE in Primary HCC
Assiut University
Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
The Second Hospital of Nanjing Medical University
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
Massachusetts General Hospital
RAD 0902
University of Alabama at Birmingham
24hr Imaging Of HCC After EOVIST
Massachusetts General Hospital
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)
Case Comprehensive Cancer Center
VM4-037
Siemens Molecular Imaging